About: A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2000 (uk) مقالة علمية تنشرت ف 1 دجنبر 2000 (ary) 2000 ഡിസംബര്‍ 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം (ml) im Dezember 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 2000 (ast) scientific article published on 01 December 2000 (en)
publication date	wds:Q73393150-0D00CAD5-506E-430F-B4CC-F823880BD075
publication date	2000-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73393150-5ABB4662-DA6C-4A71-B1B5-B3921ED6ED23
language of work or name	English
author name string	wds:Q73393150-0F1ED0A2-628D-49F5-9D47-0161D97E6137 wds:Q73393150-4F95C1FB-7796-46C8-93CA-61FCFDDA39DF wds:Q73393150-52E36C5D-32AF-47E1-9657-9F94E6C7E080 wds:Q73393150-607AA990-B082-4C47-BA24-795585A2C87E wds:Q73393150-63EDD86B-112A-4765-B5A4-6DF85B0EA6DA wds:Q73393150-8D53851E-999D-4A12-BDA1-84EA2469B755 wds:Q73393150-8FDCAF38-196B-43E5-9686-9700155567C6 wds:Q73393150-9477BEBB-043F-44A0-9A42-DF20E17213B1 wds:Q73393150-9A3D3E4F-6446-4B81-996F-F5EFB7F8E470 wds:Q73393150-B0D0C129-623C-4043-B170-15BB399E7587 wds:Q73393150-B1690410-E53C-4268-9E47-EE994EB57B78 wds:Q73393150-CE78FAC2-B36B-4762-9DB0-A041ED42D542 wds:Q73393150-E15557E2-11AB-4A10-87CB-B05EFD700B94 wds:Q73393150-FC8CB71A-3A7A-452C-8843-BE042372D174 wds:Q73393150-FFFB3EC1-B2FD-4DAC-9A66-165E58BB453F
author name string	Han C Saunders M Mitchell K Smith K Harris AL Talbot DC Stephens R O'Byrne KJ Ganesan TS Propper DJ Braybrooke JP Crew J Blann A Dobbs N Woodhull J
rdfs:label	A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis (en) A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis (nl)
skos:prefLabel	A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis (en) A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis (nl)
name	A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis (en) A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis (nl)
title	wds:Q73393150-EB1B325B-8ECA-492C-93D5-EBC8005A7279
title	A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis (en)
page(s)	wds:Q73393150-7D403CBD-F7D1-441E-B16A-65DDF71029FF
page(s)	4697-4704
instance of	wds:Q73393150-88F55DC4-E60A-401E-BE7B-7FCB56CA8CE0
instance of	scholarly article
main subject	wds:Q73393150-491E960A-DCCB-41AB-8567-6C779DB43484 wds:Q73393150-97126821-DB57-4D20-B256-D5DB84BF260D
main subject	angiogenesis angiogenesis inhibitor
PubMed ID	wds:Q73393150-EC07C9D6-6171-4817-9B35-2D1FDF283259
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11156222
PubMed ID	11156222
published in	wds:Q73393150-5796D238-F6FB-493E-B90B-4AE33625A11C
published in	Clinical Cancer Research
issue	wds:Q73393150-ACB9BDAA-54AE-4AA4-992C-C5EED57AC1F9
volume	wds:Q73393150-5306B1C8-05C7-4041-99AC-4BE302B8CB7F
issue	12
volume	6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73393150
is cites work of	Biomarkers in Drug Discovery and Development: From Target Identification through Drug Marketing Clinical biomarkers of angiogenesis inhibition Surrogate markers in antiangiogenesis clinical trials Cancer cell cytotoxicities of 1-(4-substitutedbenzoyl)-4-(4-chlorobenzhydryl)piperazine derivatives Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling Recurrent oral cancer: current and emerging therapeutic approaches. Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma. TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo Absorption, distribution and excretion of ¹⁴C-probimane in mice bearing lewis lung carcinoma Different spontaneous pulmonary metastasis inhibitions against lewis lung carcinoma in mice by bisdioxopiperazine compounds of different treatment schedules Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma Combined razoxane and radiotherapy for melanoma brain metastases. a retrospective analysis
is cites work of	wds:Q38601825-FBAFA4E1-CF68-4005-ACD4-47A5EBF04546 wds:Q55620388-4A801ED4-968D-4988-B6FD-072AB743B31A wds:Q24314623-59810A58-0FBF-4B0E-BD74-A4C9F645F7E3 wds:Q24815007-245539C5-77C7-4C6D-89C3-DD511B38A765 wds:Q35118033-6003341B-7A4F-40A7-8B70-8D38F5CE9CE8 wds:Q34409990-7AB73642-756E-4EE1-B7DC-BB611B5B0545 wds:Q35167925-93C852E6-4DE8-4288-91FB-A3866F6838A7 wds:Q36197148-0C05C7AC-9877-43AC-83DC-ECCA062125FF wds:Q37139413-4E6117B2-E1A4-4A0B-A884-BE7ACD4FC26B wds:Q24792079-7D7A57A2-C84B-49B6-BDAF-F2E84100241A wds:Q35213462-CC00512D-0584-4204-8A6C-C17C7E85E719 wds:Q46639567-B4FE5914-26CA-4B8E-98BC-09296C76059C wds:Q34410048-68372E34-CCB5-4223-9533-7F50FC2C9C26 wds:Q41340592-9D227433-25D4-43B6-8A73-46374B5242FD wds:Q36695898-8EC5EC59-C542-47A9-B5E5-9B686D27889E wds:Q36283038-7985B058-BC7E-44B8-B62D-4CC2B90F46CF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software